Clinical Data last week debuted a gene-based test that predicts whether patients with follicular non-Hodgkin’s lymphoma will respond to monotherapy with the oncologic Rituxan.
PGxPredict: Rituximab, launched by Clinical Data’s PGx Health division, is a homebrew test that interrogates for the V158F polymorphism in the FCGR3A gene. It is designed to enable oncologists to identify whether a patient is among the 20 percent of individuals who will respond strongly to the drug, made by Genentech and Biogen Idec.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.